13F filer · CIK 1395064
TAKEDA PHARMACEUTICAL CO LTD
Tokyo, M0 · filing since Q4 2023 · last filing Nov 13, 2025
Reported value
$16.4M
$-3.2M vs prior
Positions
8
New / sold out
0 / 3
Added / reduced
1 / 0
Turnover
1.2%
buys $222.8K · sells $13.9M
Top-10 weight
100.0%
Biggest buys vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | Lyell Immunopharma, Inc. | +13,722 | +33.3% | +$222.8K |
Biggest sells vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | HilleVax, Inc. | -6,724,000 | -100.0% | $-13.4M |
| Sold out | Turnstone Biologics | -895,824 | -100.0% | $-321.6K |
| Sold out | Third Harmonic Bio, Inc. | -36,835 | -100.0% | $-200.0K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Ovid Therapeutics, Inc.COM | 7,531,996 | $9.8M | 59.82% |
| 2 | Equillium, Inc.COM | 1,824,977 | $2.6M | 15.94% |
| 3 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)COM | 1,475,121 | $1.2M | 7.59% |
| 4 | Shattuck Labs, Inc.COM | 515,619 | $1.2M | 7.53% |
| 5 | Lyell Immunopharma, Inc.COM | 54,887 | $891.4K | 5.45% |
| 6 | American Well CorporationCOM | 77,733 | $478.1K | 2.92% |
| 7 | Rani Therapeutics Holdings, Inc.COM | 203,190 | $101.6K | 0.62% |
| 8 | Standard Biotools, Inc.COM | 16,515 | $21.5K | 0.13% |